PTEN and cancer: The initial publication describing the analysis of the EAC genomes reported mutational complexity with accumulated mutations including activating mutations in PIK3CA, and loss of function mutations in PTEN, PIK3R1, AKT2, and AKT3, together implicating the mTOR-PTEN pathway in some instances of this cancer [29].